<DOC>
	<DOCNO>NCT02092831</DOCNO>
	<brief_summary>This Phase 1 , open-label , randomize , 4-period crossover study design determine relative bioavailability GDC-0941 administer single dose market image formulation 3 different hardness ( hardness 1 , 2 , 3 ) single dose Phase 2 formulation healthy male female volunteer . Participants randomly assign 4 possible treatment sequence , comprise 4 period ( 1 per formulation ) , GDC-0941 administer base assigned sequence . The study expect last 8 week .</brief_summary>
	<brief_title>A Study Effect Formulation Tablet Hardness Bioavailability Pictilisib Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Male female participant 18 55 year age , inclusive , Body mass index ( BMI ) 18.5 32 kg/m2 , inclusive , Healthy , determine clinically significant finding medical history , ECG , vital sign , able swallow tolerate tether Heidelberg pH Capsule gastric pH measurement take Any medical condition history condition may , opinion investigator , contraindicate participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>